ARCHIVES

ASCO’s Lichter Says. Dingell, Stupak Urge FDA To “Act With Due Haste To Avoid Endangering Patients” Steered To ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 09 | March 7, 2008

Download PDF Visit The Full Archive

Related Articles

DCT Advisors Approve Grants Program For Trials Of BRMs

March 10, 1995

UPCI Opens New Facility; Gomella Wins NCI Award.

July 4, 2003

McKesson To Purchase US Oncology

November 5, 2010

CMS Unable to Adjust Cuts To Cancer Care

June 7, 2013

CCOPs At Six Months: Sme Exceeding Patient Goals, Most Are Meeting Schedules

March 30, 1984

Bush Says National Dialogue On Cancer Needs To Correct Problems And Move On.

March 17, 2000